 | • レポートコード：MRC2012B1260 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Service & Software |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、タンパク質医薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。タンパク質医薬品の種類別市場規模（抗体医薬品、ペプチドホルモン、血液製剤、酵素）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Eli Lilly、Novo Nordisk、Schering-Plough Corporation、Abbott Laboratories、Bristol-Myers Squibb、UCB Group、Dendreon Corporation、Johnson＆Johnson、Genentech、Biogen Idec、Amgen Inc.、 ・地域別グローバル市場分析 2015年-2020年 ・タンパク質医薬品の北米市場（アメリカ、カナダ、メキシコ） ・タンパク質医薬品のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・タンパク質医薬品のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・タンパク質医薬品の南米市場（ブラジル、アルゼンチン） ・タンパク質医薬品の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：抗体医薬品、ペプチドホルモン、血液製剤、酵素 ・用途別分析：病院、診療所、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Protein Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Protein Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Protein Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Protein Drugs market has been segmented into:
Antibody Drugs
Peptide Hormones
Blood Products
Enzymes
By Application, Protein Drugs has been segmented into:
Hospitals
Clinics
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Protein Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Protein Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Protein Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Protein Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Protein Drugs Market Share Analysis
Protein Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Protein Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Protein Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Protein Drugs are:
Eli Lilly
Novo Nordisk
Schering-Plough Corporation
Abbott Laboratories
Bristol-Myers Squibb
UCB Group
Dendreon Corporation
Johnson＆Johnson
Genentech
Biogen Idec
Amgen Inc.
Table of Contents
1 Protein Drugs Market Overview
1.1 Product Overview and Scope of Protein Drugs
1.2 Classification of Protein Drugs by Type
1.2.1 Global Protein Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Protein Drugs Revenue Market Share by Type in 2019
1.2.3 Antibody Drugs
1.2.4 Peptide Hormones
1.2.5 Blood Products
1.2.6 Enzymes
1.3 Global Protein Drugs Market by Application
1.3.1 Overview: Global Protein Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Protein Drugs Market by Regions
1.4.1 Global Protein Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Protein Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Protein Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Protein Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Protein Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Protein Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Protein Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Eli Lilly SWOT Analysis
2.1.4 Eli Lilly Product and Services
2.1.5 Eli Lilly Protein Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novo Nordisk
2.2.1 Novo Nordisk Details
2.2.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novo Nordisk SWOT Analysis
2.2.4 Novo Nordisk Product and Services
2.2.5 Novo Nordisk Protein Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Schering-Plough Corporation
2.3.1 Schering-Plough Corporation Details
2.3.2 Schering-Plough Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Schering-Plough Corporation SWOT Analysis
2.3.4 Schering-Plough Corporation Product and Services
2.3.5 Schering-Plough Corporation Protein Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbott Laboratories
2.4.1 Abbott Laboratories Details
2.4.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbott Laboratories SWOT Analysis
2.4.4 Abbott Laboratories Product and Services
2.4.5 Abbott Laboratories Protein Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bristol-Myers Squibb SWOT Analysis
2.5.4 Bristol-Myers Squibb Product and Services
2.5.5 Bristol-Myers Squibb Protein Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 UCB Group
2.6.1 UCB Group Details
2.6.2 UCB Group Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 UCB Group SWOT Analysis
2.6.4 UCB Group Product and Services
2.6.5 UCB Group Protein Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Dendreon Corporation
2.7.1 Dendreon Corporation Details
2.7.2 Dendreon Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Dendreon Corporation SWOT Analysis
2.7.4 Dendreon Corporation Product and Services
2.7.5 Dendreon Corporation Protein Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Johnson＆Johnson
2.8.1 Johnson＆Johnson Details
2.8.2 Johnson＆Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Johnson＆Johnson SWOT Analysis
2.8.4 Johnson＆Johnson Product and Services
2.8.5 Johnson＆Johnson Protein Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Genentech
2.9.1 Genentech Details
2.9.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Genentech SWOT Analysis
2.9.4 Genentech Product and Services
2.9.5 Genentech Protein Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 Biogen Idec
2.10.1 Biogen Idec Details
2.10.2 Biogen Idec Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Biogen Idec SWOT Analysis
2.10.4 Biogen Idec Product and Services
2.10.5 Biogen Idec Protein Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.11 Amgen Inc.
2.11.1 Amgen Inc. Details
2.11.2 Amgen Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Amgen Inc. SWOT Analysis
2.11.4 Amgen Inc. Product and Services
2.11.5 Amgen Inc. Protein Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Protein Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Protein Drugs Players Market Share
3.2.2 Top 10 Protein Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Protein Drugs Revenue and Market Share by Regions
4.2 North America Protein Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Protein Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Protein Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Protein Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Protein Drugs Revenue and Growth Rate (2015-2020)
5 North America Protein Drugs Revenue by Countries
5.1 North America Protein Drugs Revenue by Countries (2015-2020)
5.2 USA Protein Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Protein Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Protein Drugs Revenue and Growth Rate (2015-2020)
6 Europe Protein Drugs Revenue by Countries
6.1 Europe Protein Drugs Revenue by Countries (2015-2020)
6.2 Germany Protein Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Protein Drugs Revenue and Growth Rate (2015-2020)
6.4 France Protein Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Protein Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Protein Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Protein Drugs Revenue by Countries
7.1 Asia-Pacific Protein Drugs Revenue by Countries (2015-2020)
7.2 China Protein Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Protein Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Protein Drugs Revenue and Growth Rate (2015-2020)
7.5 India Protein Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Protein Drugs Revenue and Growth Rate (2015-2020)
8 South America Protein Drugs Revenue by Countries
8.1 South America Protein Drugs Revenue by Countries (2015-2020)
8.2 Brazil Protein Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Protein Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Protein Drugs by Countries
9.1 Middle East & Africa Protein Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Protein Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Protein Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Protein Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Protein Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Protein Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Protein Drugs Market Forecast by Type (2019-2024)
10.3 Antibody Drugs Revenue Growth Rate (2015-2025)
10.4 Peptide Hormones Revenue Growth Rate (2015-2025)
10.5 Blood Products Revenue Growth Rate (2015-2025)
10.6 Enzymes Revenue Growth Rate (2015-2025)
11 Global Protein Drugs Market Segment by Application
11.1 Global Protein Drugs Revenue Market Share by Application (2015-2020)
11.2 Protein Drugs Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Protein Drugs Market Size Forecast (2021-2025)
12.1 Global Protein Drugs Market Size Forecast (2021-2025)
12.2 Global Protein Drugs Market Forecast by Regions (2021-2025)
12.3 North America Protein Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Protein Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Protein Drugs Revenue Market Forecast (2021-2025)
12.6 South America Protein Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Protein Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Protein Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Protein Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Protein Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Protein Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Eli Lilly Corporate Information, Location and Competitors
Table 6. Eli Lilly Protein Drugs Major Business
Table 7. Eli Lilly Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 8. Eli Lilly SWOT Analysis
Table 9. Eli Lilly Protein Drugs Product and Solutions
Table 10. Eli Lilly Protein Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Novo Nordisk Corporate Information, Location and Competitors
Table 12. Novo Nordisk Protein Drugs Major Business
Table 13. Novo Nordisk Protein Drugs Total Revenue (USD Million) (2018-2019)
Table 14. Novo Nordisk SWOT Analysis
Table 15. Novo Nordisk Protein Drugs Product and Solutions
Table 16. Novo Nordisk Protein Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Schering-Plough Corporation Corporate Information, Location and Competitors
Table 18. Schering-Plough Corporation Protein Drugs Major Business
Table 19. Schering-Plough Corporation Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 20. Schering-Plough Corporation SWOT Analysis
Table 21. Schering-Plough Corporation Protein Drugs Product and Solutions
Table 22. Schering-Plough Corporation Protein Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Abbott Laboratories Corporate Information, Location and Competitors
Table 24. Abbott Laboratories Protein Drugs Major Business
Table 25. Abbott Laboratories Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 26. Abbott Laboratories SWOT Analysis
Table 27. Abbott Laboratories Protein Drugs Product and Solutions
Table 28. Abbott Laboratories Protein Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 30. Bristol-Myers Squibb Protein Drugs Major Business
Table 31. Bristol-Myers Squibb Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 32. Bristol-Myers Squibb SWOT Analysis
Table 33. Bristol-Myers Squibb Protein Drugs Product and Solutions
Table 34. Bristol-Myers Squibb Protein Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. UCB Group Corporate Information, Location and Competitors
Table 36. UCB Group Protein Drugs Major Business
Table 37. UCB Group Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 38. UCB Group SWOT Analysis
Table 39. UCB Group Protein Drugs Product and Solutions
Table 40. UCB Group Protein Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Dendreon Corporation Corporate Information, Location and Competitors
Table 42. Dendreon Corporation Protein Drugs Major Business
Table 43. Dendreon Corporation Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 44. Dendreon Corporation SWOT Analysis
Table 45. Dendreon Corporation Protein Drugs Product and Solutions
Table 46. Dendreon Corporation Protein Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Johnson＆Johnson Corporate Information, Location and Competitors
Table 48. Johnson＆Johnson Protein Drugs Major Business
Table 49. Johnson＆Johnson Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 50. Johnson＆Johnson SWOT Analysis
Table 51. Johnson＆Johnson Protein Drugs Product and Solutions
Table 52. Johnson＆Johnson Protein Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Genentech Corporate Information, Location and Competitors
Table 54. Genentech Protein Drugs Major Business
Table 55. Genentech Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 56. Genentech SWOT Analysis
Table 57. Genentech Protein Drugs Product and Solutions
Table 58. Genentech Protein Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Biogen Idec Corporate Information, Location and Competitors
Table 60. Biogen Idec Protein Drugs Major Business
Table 61. Biogen Idec Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 62. Biogen Idec SWOT Analysis
Table 63. Biogen Idec Protein Drugs Product and Solutions
Table 64. Biogen Idec Protein Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Amgen Inc. Corporate Information, Location and Competitors
Table 66. Amgen Inc. Protein Drugs Major Business
Table 67. Amgen Inc. Protein Drugs Total Revenue (USD Million) (2017-2018)
Table 68. Amgen Inc. SWOT Analysis
Table 69. Amgen Inc. Protein Drugs Product and Solutions
Table 70. Amgen Inc. Protein Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Protein Drugs Revenue (Million USD) by Players (2015-2020)
Table 72. Global Protein Drugs Revenue Share by Players (2015-2020)
Table 73. Global Protein Drugs Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Protein Drugs Revenue Market Share by Regions (2015-2020)
Table 75. North America Protein Drugs Revenue by Countries (2015-2020)
Table 76. North America Protein Drugs Revenue Market Share by Countries (2015-2020)
Table 77. Europe Protein Drugs Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Protein Drugs Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Protein Drugs Revenue by Countries (2015-2020)
Table 80. South America Protein Drugs Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Protein Drugs Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Protein Drugs Revenue Market Share by Countries (2015-2020)
Table 83. Global Protein Drugs Revenue (Million USD) by Type (2015-2020)
Table 84. Global Protein Drugs Revenue Share by Type (2015-2020)
Table 85. Global Protein Drugs Revenue Forecast by Type (2021-2025)
Table 86. Global Protein Drugs Revenue by Application (2015-2020)
Table 87. Global Protein Drugs Revenue Share by Application (2015-2020)
Table 88. Global Protein Drugs Revenue Forecast by Application (2021-2025)
Table 89. Global Protein Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Protein Drugs Picture
Figure 2. Global Protein Drugs Revenue Market Share by Type in 2019
Figure 3. Antibody Drugs Picture
Figure 4. Peptide Hormones Picture
Figure 5. Blood Products Picture
Figure 6. Enzymes Picture
Figure 7. Protein Drugs Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Other Picture
Figure 11. Global Protein Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Protein Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Protein Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Protein Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Protein Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Protein Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Protein Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Protein Drugs Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Protein Drugs Revenue Market Share in 2019
Figure 20. Global Top 10 Players Protein Drugs Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Protein Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Protein Drugs Revenue Market Share by Regions (2015-2020)
Figure 24. Global Protein Drugs Revenue Market Share by Regions in 2018
Figure 25. North America Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 26. Europe Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 28. South America Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 30. North America Protein Drugs Revenue Market Share by Countries (2015-2020)
Figure 31. North America Protein Drugs Revenue Market Share by Countries in 2019
Figure 32. USA Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 33. Canada Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 35. Europe Protein Drugs Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Protein Drugs Revenue Market Share by Countries in 2019
Figure 37. Germany Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 38. UK Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 39. France Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 40. Russia Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 41. Italy Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Protein Drugs Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Protein Drugs Revenue Market Share by Countries in 2019
Figure 44. China Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Japan Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 46. Korea Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 47. India Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 49. South America Protein Drugs Revenue Market Share by Countries (2015-2020)
Figure 50. South America Protein Drugs Revenue Market Share by Countries in 2019
Figure 51. Brazil Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Protein Drugs Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Protein Drugs Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 56. UAE Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Protein Drugs Revenue and Growth Rate (2015-2020)
Figure 59. Global Protein Drugs Revenue Share by Type (2015-2020)
Figure 60. Global Protein Drugs Revenue Share by Type in 2019
Figure 61. Global Protein Drugs Market Share Forecast by Type (2021-2025)
Figure 62. Global Antibody Drugs Revenue Growth Rate (2015-2020)
Figure 63. Global Peptide Hormones Revenue Growth Rate (2015-2020)
Figure 64. Global Blood Products Revenue Growth Rate (2015-2020)
Figure 65. Global Enzymes Revenue Growth Rate (2015-2020)
Figure 66. Global Protein Drugs Revenue Share by Application (2015-2020)
Figure 67. Global Protein Drugs Revenue Share by Application in 2019
Figure 68. Global Protein Drugs Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 70. Global Clinics Revenue Growth Rate (2015-2020)
Figure 71. Global Other Revenue Growth Rate (2015-2020)
Figure 72. Global Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Protein Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Protein Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Protein Drugs Revenue Market Forecast (2021-2025)
Figure 76. Europe Protein Drugs Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Protein Drugs Revenue Market Forecast (2021-2025)
Figure 78. South America Protein Drugs Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Protein Drugs Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
受容体チロシンプロテインキナーゼ標的薬の世界市場（～2026年） Market Analysis and Insights: Global Receptor Tyrosine Protein Kinase Targeted Drugs Market The global Receptor Tyrosine Protein Kinase Targeted Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Receptor Tyrosine P…- 受容体型チロシンプロテインキナーゼ標的薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Receptor Tyrosine Protein Kinase Targeted Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. T…
- 融合タンパク質の世界市場（～2026年） Market Analysis and Insights: Global Fusion Protein Market The global Fusion Protein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Fusion Protein Scope and Market Size Fusion Protein market is segmented by Type, and …
- 抗原虫薬の世界市場（～2026年） Antiprotozoal agents (ATC code: ATC P01) is a class of pharmaceuticals used in treatment of protozoan infection. Antiprotozoals are used to treat protozoal infections, which include amebiasis, giardiasis, cryptosporidiosis, microsporidiosis, malaria, babesiosis, trypanosomiasis, Chagas disease, leis…
- インフルエンザ薬の世界市場（～2026年） Market Analysis and Insights: Global Influenza Drugs Market The global Influenza Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Influenza Drugs Scope and Market Size Influenza Drugs market is segmented by Type, …